BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34264468)

  • 1. An Ex Vivo Model for Assessing Growth and Survivability of Staphylococcus aureus in Whole Human Blood.
    Gimza BD; Marroquin SM; Shaw LN
    Methods Mol Biol; 2021; 2341():127-131. PubMed ID: 34264468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and Stress Tolerance Comprise Independent Metabolic Strategies Critical for Staphylococcus aureus Infection.
    Kim GL; Hooven TA; Norambuena J; Li B; Boyd JM; Yang JH; Parker D
    mBio; 2021 Jun; 12(3):e0081421. PubMed ID: 34101490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clumping factor A, von Willebrand factor-binding protein and von Willebrand factor anchor Staphylococcus aureus to the vessel wall.
    Claes J; Liesenborghs L; Peetermans M; Veloso TR; Missiakas D; Schneewind O; Mancini S; Entenza JM; Hoylaerts MF; Heying R; Verhamme P; Vanassche T
    J Thromb Haemost; 2017 May; 15(5):1009-1019. PubMed ID: 28182324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artificial Selection for Pathogenicity Mutations in
    McLean K; Holmes EA; Penewit K; Lee DK; Hardy SR; Ren M; Krist MP; Huang K; Waalkes A; Salipante SJ
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of host and Staphylococcus aureus protease-system regulates virulence and pathogenicity.
    Singh V; Phukan UJ
    Med Microbiol Immunol; 2019 Oct; 208(5):585-607. PubMed ID: 30483863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Staphylococcus aureus Factors Required for Pathogenicity and Growth in Human Blood.
    Connolly J; Boldock E; Prince LR; Renshaw SA; Whyte MK; Foster SJ
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808156
    [No Abstract]   [Full Text] [Related]  

  • 7. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.
    McAdow M; Kim HK; Dedent AC; Hendrickx AP; Schneewind O; Missiakas DM
    PLoS Pathog; 2011 Oct; 7(10):e1002307. PubMed ID: 22028651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virulence regulation in Staphylococcus aureus: the need for in vivo analysis of virulence factor regulation.
    Pragman AA; Schlievert PM
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):147-54. PubMed ID: 15364098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple ligands of von Willebrand factor-binding protein (vWbp) promote Staphylococcus aureus clot formation in human plasma.
    Thomer L; Schneewind O; Missiakas D
    J Biol Chem; 2013 Sep; 288(39):28283-92. PubMed ID: 23960083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and Clinical Evidence for the Role of Toxins in
    Bennett MR; Thomsen IP
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32575633
    [No Abstract]   [Full Text] [Related]  

  • 11. MgrA Governs Adherence, Host Cell Interaction, and Virulence in a Murine Model of Bacteremia Due to Staphylococcus aureus.
    Li L; Wang G; Cheung A; Abdelhady W; Seidl K; Xiong YQ
    J Infect Dis; 2019 Aug; 220(6):1019-1028. PubMed ID: 31177268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOST-PATHOGEN INTERACTION IN INFECTIONS DUE TO STAPHYLOCOCCUS AUREUS. STAPHYLOCOCCUS AUREUS VIRULENCE FACTORS.
    Drăgulescu EC; Codiţă I
    Roum Arch Microbiol Immunol; 2015; 74(1-2):46-64. PubMed ID: 26727854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics in studies of Staphylococcus aureus virulence.
    Bonar E; Wójcik I; Wladyka B
    Acta Biochim Pol; 2015; 62(3):367-81. PubMed ID: 26307769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.
    Alonzo F; Benson MA; Chen J; Novick RP; Shopsin B; Torres VJ
    Mol Microbiol; 2012 Jan; 83(2):423-35. PubMed ID: 22142035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of moonlighting proteins in Staphylococcus aureus infection.
    Hemmadi V; Biswas M
    Arch Microbiol; 2021 Mar; 203(2):481-498. PubMed ID: 33048189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of pathogenic factors potentially involved in Staphylococcus aureus keratitis using proteomics.
    Khan S; Cole N; Hume EB; Garthwaite LL; Nguyen-Khuong T; Walsh BJ; Willcox MD
    Exp Eye Res; 2016 Oct; 151():171-8. PubMed ID: 27590660
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Pietrocola G; Nobile G; Rindi S; Speziale P
    Front Cell Infect Microbiol; 2017; 7():166. PubMed ID: 28529927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The purine biosynthesis regulator PurR moonlights as a virulence regulator in
    Sause WE; Balasubramanian D; Irnov I; Copin R; Sullivan MJ; Sommerfield A; Chan R; Dhabaria A; Askenazi M; Ueberheide B; Shopsin B; van Bakel H; Torres VJ
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13563-13572. PubMed ID: 31217288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence factors and clonal diversity of Staphylococcus aureus in colonization and wound infection with emphasis on diabetic foot infection.
    Shettigar K; Murali TS
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2235-2246. PubMed ID: 32683595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Expression of von Willebrand Factor-Binding Protein Determines Joint-Invading Capacity of Staphylococcus aureus, a Core Mechanism of Septic Arthritis.
    Na M; Hu Z; Mohammad M; Stroparo MDN; Ali A; Fei Y; Jarneborn A; Verhamme P; Schneewind O; Missiakas D; Jin T
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.